Literature DB >> 23400591

Role of pre-operative multiple gated acquisition scanning in predicting long-term outcome in patients undergoing elective abdominal aortic aneurysm repair.

Hashem M Barakat1, Yousef Shahin, Junaid A Khan, Peter T McCollum, Ian C Chetter.   

Abstract

OBJECTIVE: To determine whether resting pre-operative left ventricular ejection fraction (LVEF) estimated by multiple gated acquisition scanning (MUGA) predicts long-term survival in patients undergoing elective abdominal aortic aneurysm (AAA) repair.
METHODS: A retrospective study of MUGA scans which were performed to estimate pre-operative resting LVEF in 127 patients [106 (83 %) males, mean age 74 ± 7.6 years] who underwent elective AAA repair over a period of 4 years from March 2007. We compared outcomes and long-term survival between patients who had a pre-operative LVEF ≤ 40 % (Group 1, n = 60) and LVEF > 40 % (Group 2, n = 67).
RESULTS: Overall 19 (15 %) patients died during the follow-up period (13 patients in group 1 and 6 patients in group 2). 30-day mortality was 8 %. There was no significant difference between group 1 and 2 in terms of patients' mean age or median length of hospital stay (8 days for both groups, p = 0.61). However, group 2 had more females than group 1(18 vs. 3, p = 0.001). Median survival for patients in group 2 was significantly higher than patients in group 1 (1,258 days vs. 1,000 days, p = 0.03). In a Cox regression model which included age, sex, smoking status and LVEF as covariates, only smoking status and LVEF predicted survival [Hazard ratio (HR) = 1.06, p = 0.04 and HR = 0.93, p = 0.00, respectively].
CONCLUSION: This study shows that there is a role for pre-operative MUGA scan assessment of resting LVEF in predicting long-term survival post elective AAA repair and that the lower the pre-operative LVEF the poorer the long-term outcome.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23400591     DOI: 10.1007/s00268-013-1939-3

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  32 in total

1.  ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery.

Authors:  Lee A Fleisher; Joshua A Beckman; Kenneth A Brown; Hugh Calkins; Elliott Chaikof; Kirsten E Fleischmann; William K Freeman; James B Froehlich; Edward K Kasper; Judy R Kersten; Barbara Riegel; John F Robb; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Elliott M Antman; Christopher E Buller; Mark A Creager; Steven M Ettinger; David P Faxon; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Sharon A Hunt; Bruce W Lytle; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Lynn G Tarkington; Clyde W Yancy
Journal:  Circulation       Date:  2007-09-27       Impact factor: 29.690

2.  Assessment of left ventricular function: comparison between radionuclide angiography and semiquantitative two-dimensional echocardiographic analysis.

Authors:  M Gottsauner-Wolf; J Schedlmayer-Duit; G Porenta; M Gwechenberger; K Huber; D Glogar; P Probst; H Sochor
Journal:  Eur J Nucl Med       Date:  1996-12

3.  Left ventricular ejection fraction as a prognostic guide in surgical treatment of coronary and valvular heart disease.

Authors:  P F Cohn; R Gorlin; L H Cohn; J J Collins
Journal:  Am J Cardiol       Date:  1974-08       Impact factor: 2.778

Review 4.  Preoperative cardiac risk assessment for patients having peripheral vascular surgery.

Authors:  T Wong; A S Detsky
Journal:  Ann Intern Med       Date:  1992-05-01       Impact factor: 25.391

5.  Predictors of outcome after elective endovascular abdominal aortic aneurysm repair and external validation of a risk prediction model.

Authors:  Brendan Wisniowski; Mary Barnes; Jason Jenkins; Nicholas Boyne; Allan Kruger; Philip J Walker
Journal:  J Vasc Surg       Date:  2011-07-23       Impact factor: 4.268

6.  Reliability of bedside evaluation in determining left ventricular function: correlation with left ventricular ejection fraction determined by radionuclide ventriculography.

Authors:  S J Mattleman; A H Hakki; A S Iskandrian; B L Segal; S A Kane
Journal:  J Am Coll Cardiol       Date:  1983-02       Impact factor: 24.094

7.  The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure.

Authors:  Jeptha P Curtis; Seth I Sokol; Yongfei Wang; Saif S Rathore; Dennis T Ko; Farid Jadbabaie; Edward L Portnay; Stephen J Marshalko; Martha J Radford; Harlan M Krumholz
Journal:  J Am Coll Cardiol       Date:  2003-08-20       Impact factor: 24.094

8.  Prediction of cardiac risk prior to elective abdominal aortic surgery: role of multiple gated acquisition scan.

Authors:  Christos D Karkos; George J L Thomson; Robert Hughes; Miland Joshi; Mohamed S Baguneid; Jonathan C Hill; Umasankar S Mukhopadhyay
Journal:  World J Surg       Date:  2003-08-21       Impact factor: 3.352

9.  Risk prediction for perioperative mortality of endovascular vs open repair of abdominal aortic aneurysms using the Medicare population.

Authors:  Kristina A Giles; Marc L Schermerhorn; A James O'Malley; Philip Cotterill; Ami Jhaveri; Frank B Pomposelli; Bruce E Landon
Journal:  J Vasc Surg       Date:  2009-02-26       Impact factor: 4.268

10.  Comparative early and late cardiac morbidity among patients requiring different vascular surgery procedures.

Authors:  G J L'Italien; R P Cambria; B S Cutler; J A Leppo; S D Paul; D C Brewster; R C Hendel; W M Abbott; K A Eagle
Journal:  J Vasc Surg       Date:  1995-06       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.